These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38266205)

  • 1. Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy.
    Dawkins B; Absolom K; Hewison J; Warrington L; Hudson E; Holch P; Carter R; Gibson A; Holmes M; Rogers Z; Dickinson S; Morris C; Woroncow B; Brown J; Hulme C; Velikova G
    JCO Oncol Pract; 2024 Apr; 20(4):581-590. PubMed ID: 38266205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.
    Absolom K; Warrington L; Hudson E; Hewison J; Morris C; Holch P; Carter R; Gibson A; Holmes M; Clayton B; Rogers Z; McParland L; Conner M; Glidewell L; Woroncow B; Dawkins B; Dickinson S; Hulme C; Brown J; Velikova G
    J Clin Oncol; 2021 Mar; 39(7):734-747. PubMed ID: 33417506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment.
    Absolom K; Holch P; Warrington L; Samy F; Hulme C; Hewison J; Morris C; Bamforth L; Conner M; Brown J; Velikova G;
    BMC Cancer; 2017 May; 17(1):318. PubMed ID: 28482877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting.
    Warrington L; Absolom K; Holch P; Gibson A; Clayton B; Velikova G
    BMJ Open; 2019 Feb; 9(1):e025185. PubMed ID: 30782751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention.
    Holch P; Absolom KL; Henry AM; Walker K; Gibson A; Hudson E; Rogers Z; Holmes M; Peacock R; Pini S; Gilbert A; Davidson S; Routledge J; Murphy A; Franks K; Hulme C; Hewison J; Morris C; McParland L; Brown J; Velikova G
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):664-676. PubMed ID: 36241128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
    Hartwell D; Jones J; Baxter L; Shepherd J
    Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
    Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
    J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of Internet-based problem-solving guided self-help treatment in comparison with enhanced usual care for depressed outpatients waiting for face-to-face treatment: A randomized controlled trial.
    Kolovos S; Kenter RM; Bosmans JE; Beekman AT; Cuijpers P; Kok RN; van Straten A
    J Affect Disord; 2016 Aug; 200():284-92. PubMed ID: 27155071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy.
    Holch P; Pini S; Henry AM; Davidson S; Routledge J; Brown J; Absolom K; Gilbert A; Franks K; Hulme C; Morris C; Velikova G;
    Pilot Feasibility Stud; 2018; 4():110. PubMed ID: 29992040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a primary healthcare intervention to treat male lower urinary tract symptoms: the TRIUMPH cluster randomised controlled trial.
    Cochrane M; Drake MJ; Worthington J; Frost J; Cotterill N; Fader M; McGeagh L; Hashim H; Lane A; Macaulay M; MacNeill S; Rees J; Ridd MJ; Robles LA; Sanderson E; Taylor G; Taylor J; Noble S
    BMJ Open; 2024 Jan; 14(1):e075704. PubMed ID: 38296301
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.